The energetic cost of induced fit catalysis: Crystal structures of trypsinogen mutants with enhanced activity and inhibitor affinity
暂无分享,去创建一个
C. Jeffery | D Ringe | L Hedstrom | M. Cahoon | C J Jeffery | A Pasternak | A White | N Medina | M Cahoon | A. White | A. Pasternak | Dagmar Ringe | Lizbeth Hedstrom | N. Medina
[1] J. Hanson,et al. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors. , 1989, Biochemistry.
[2] A. Fersht. Enzyme structure and mechanism , 1977 .
[3] J. Sambrook,et al. The single-chain form of tissue-type plasminogen activator has catalytic activity: studies with a mutant enzyme that lacks the cleavage site. , 1989, Biochemistry.
[4] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[5] K. Brady,et al. Inhibition of chymotrypsin by peptidyl trifluoromethyl ketones: determinants of slow-binding kinetics. , 1990, Biochemistry.
[6] Daniel Herschlag,et al. The role of induced fit and conformational changes of enzymes in specificity and catalysis , 1988 .
[7] D. Koshland. Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. Rutter,et al. Transition-state characterization: a new approach combining inhibitor analogues and variation in enzyme structure. , 1992, Biochemistry.
[9] R. Huber,et al. Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. , 1977, Journal of molecular biology.
[10] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[11] M. Karplus,et al. Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.
[12] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[13] A. Brünger. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures , 1992, Nature.
[14] P. Bartlett,et al. Phosphonamidates as transition-state analogue inhibitors of thermolysin. , 1983, Biochemistry.
[15] R. Fletterick,et al. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI. , 1993, Journal of molecular biology.
[16] M Bolognesi,et al. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation. , 1982, Journal of molecular biology.
[17] D. Ringe,et al. Comparison of anionic and cationic trypsinogens: The anionic activation domain is more flexible in solution and differs in its mode of BPTI binding in the crystal structure , 2008, Protein science : a publication of the Protein Society.
[18] M. Lazdunski,et al. Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges. , 1972, Biochemistry.
[19] T. Lin,et al. Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen. , 1998, Biochemistry.
[20] R. Huber,et al. Induction of the bovine trypsinogen—trypsin transition by peptides sequentially similar to the N‐terminus of trypsin , 1976, FEBS letters.
[21] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[22] R. Huber,et al. Structural basis of the activation and action of trypsin , 1978 .
[23] W. Rutter,et al. Converting trypsin to chymotrypsin: residue 172 is a substrate specificity determinant. , 1994, Biochemistry.
[24] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[25] L. Hedstrom,et al. The roles of conserved carboxylate residues in IMP dehydrogenase and identification of a transition state analog. , 1997, Biochemistry.
[26] A. Warshel. Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites* , 1998, The Journal of Biological Chemistry.
[27] R. Huber,et al. Lysine 156 promotes the anomalous proenzyme activity of tPA: X‐ray crystal structure of single‐chain human tPA , 1997, The EMBO journal.
[28] S. Benkovic,et al. Solvation, Reorganization Energy, and Biological Catalysis* , 1998, The Journal of Biological Chemistry.
[29] H. Lipson. Crystal Structures , 1949, Nature.
[30] T. Lin,et al. Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases. , 1996, Biochemistry.
[31] W. Rutter,et al. Converting trypsin to chymotrypsin: the role of surface loops. , 1992, Science.
[32] R. Stroud,et al. Structure of bovine trypsinogen at 1.9 A resolution. , 1977, Biochemistry.
[33] C. Post,et al. Reexamination of induced fit as a determinant of substrate specificity in enzymatic reactions. , 1995, Biochemistry.
[34] A. Fersht,et al. Catalysis, binding and enzyme-substrate complementarity , 1974, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[35] Axel T. Brunger,et al. Model bias in macromolecular crystal structures , 1992 .